Xinmei Zhang Selected Research

Adenomyosis

6/2022	Long-Term Pregnancy Outcomes of Patients with Diffuse Adenomyosis after Double-Flap Adenomyomectomy.
11/2020	Efficacy of the levonorgestrel-releasing intrauterine device is associated with different subtypes of adenomyosis: a retrospective study.
1/2020	A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis.
1/2020	The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea.
1/2019	[Progress on medical treatment in the management of adenomyosis].
1/2019	[Stratified treatment and management of adenomyosis].
1/2019	Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution.
1/2019	[The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis].
1/2019	[Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis].
9/2014	Increased endometrial expression of CC-chemokine receptor-1 in women with adenomyosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinmei Zhang Research Topics

Disease

38	Endometriosis 02/2022 - 05/2003
13	Pain (Aches) 01/2022 - 11/2009
12	Adenomyosis 06/2022 - 09/2008
7	Neoplasms (Cancer) 01/2021 - 10/2003
7	Obesity 01/2019 - 05/2008
6	Dysmenorrhea (Menstrual Pain) 01/2020 - 05/2003
6	Insulin Resistance 01/2019 - 05/2008
3	Infertility (Sterility) 01/2021 - 08/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 05/2008
2	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 03/2016
2	Hyperalgesia 01/2020 - 01/2013
2	Cysts 12/2019 - 05/2013
2	Interstitial Pregnancy 04/2018 - 11/2004
2	Type 2 Diabetes Mellitus (MODY) 12/2017 - 05/2015
2	Ovarian Neoplasms (Ovarian Cancer) 03/2017 - 03/2016
2	Hyperglycemia 07/2014 - 10/2013
2	Female Genital Diseases 06/2014 - 07/2013
1	Vitreous Detachment (Posterior Vitreous Detachment) 02/2022
1	vitreous floaters 02/2022
1	Uterine Perforation 01/2022
1	Lacerations 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Adenocarcinoma 01/2021
1	Carcinogenesis 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Atrophic Gastritis 01/2021
1	Gastritis 01/2021
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2020
1	Hypertrophy 01/2020
1	Atrophy 01/2020
1	Muscular Atrophy (Muscle Atrophy) 01/2020
1	Atrophic Muscular Disorders 01/2020

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2009
8	Pharmaceutical PreparationsIBA 01/2020 - 03/2016
7	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 05/2008
5	Messenger RNA (mRNA)IBA 01/2022 - 09/2014
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2022 - 12/2013
4	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2014
4	Levonorgestrel (Plan B)FDA LinkGeneric 11/2020 - 01/2019
3	Estrogens (Estrogen)FDA Link 01/2021 - 01/2018
3	RON proteinIBA 01/2021 - 03/2017
3	Purinergic P2X3 ReceptorsIBA 01/2020 - 01/2017
3	Mifepristone (RU 486)FDA Link 01/2020 - 01/2019
3	Hormones (Hormone)IBA 01/2019 - 07/2013
3	EnzymesIBA 01/2018 - 04/2011
3	pigment epithelium-derived factorIBA 11/2012 - 04/2011
2	Triptorelin Pamoate (Trelstar)FDA Link 02/2022 - 07/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2013
2	Netrin-1IBA 01/2021 - 04/2020
2	stearic acid (magnesium stearate)FDA LinkGeneric 01/2020 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2017
2	OligosaccharidesIBA 01/2020 - 01/2017
2	ChitosanIBA 01/2020 - 01/2017
2	fibroblast growth factor 21IBA 01/2019 - 05/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 12/2017
2	SteroidsIBA 01/2019 - 09/2008
2	Insulin (Novolin)FDA Link 12/2017 - 07/2014
2	ImmunosorbentsIBA 12/2013 - 04/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2013 - 05/2010
1	Indicators and Reagents (Reagents)IBA 06/2022
1	4-hexyloxyaniline (HOA)IBA 02/2022
1	Competitive Endogenous RNAIBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Circular RNAIBA 01/2022
1	Dinoprostone (PGE2)FDA Link 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2021
1	InflammasomesIBA 01/2021
1	A-factor (Streptomyces)IBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021
1	ResveratrolIBA 01/2021
1	N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA 01/2021
1	neogeninIBA 04/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 04/2020
1	AndrogensIBA 01/2020
1	Ligand-Gated Ion ChannelsIBA 01/2020
1	pyrazolanthroneIBA 01/2020
1	Adenosine Diphosphate (ADP)IBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Liposomes (Liposome)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Testosterone (Sustanon)FDA Link 01/2020
1	Activating Transcription Factor 3IBA 01/2020
1	JNK Mitogen-Activated Protein KinasesIBA 01/2020

Therapy/Procedure

4	Therapeutics 02/2022 - 12/2013
3	Hysterectomy 01/2019 - 07/2013
3	Drug Therapy (Chemotherapy) 01/2019 - 03/2016
3	Transplantation 04/2018 - 02/2011
2	Aftercare (After-Treatment) 01/2022 - 01/2020
2	Heterologous Transplantation (Xenotransplantation) 01/2021 - 01/2021
2	Intrauterine Devices (Intrauterine Device) 11/2020 - 09/2008
2	Curettage 11/2018 - 11/2004
2	Microspheres (Microsphere) 02/2011 - 09/2007
1	Solid-State Lasers 02/2022
1	Surgical Instruments (Clip) 01/2022
1	Injections 07/2021
1	Castration 01/2020
1	High-Protein Diet 01/2020